Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Lucid Group Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Lucid Group Inc trades at $3.28 (market cap $1.30B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 23.8× Lucid Group Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals.
| GEHC | LCID | |
|---|---|---|
Market Cap | $30.93B | $1.30B |
Volume | 5,033,451 | 16,941,666 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $21.67 |
52-Week Low | $59.48 | $3.29 |
Enterprise Value | $39.39B | $4.19B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 45 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Lucid Group (LCID) trades at $3.36, down 2.33% amid ongoing operational challenges. The stock shows bearish technical signals with all moving averages indicating selling pressure, though oversold RSI levels suggest potential near-term bounce. Fundamentally, the company continues to burn cash with negative gross margins of -96.56% and widening losses, while recent news highlights delayed product launches and aggressive cost-cutting initiatives targeting $1.4 billion in savings.
LCID faces significant headwinds with persistent losses and cash burn threatening viability, though strategic partnerships and cost reduction efforts provide some optimism. The stock trades at deep discounts to sales and book value, but requires successful execution on new vehicle launches and substantial margin improvement to justify analyst consensus price target of $7.00, representing 109% upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
